Delivery Order SPE2DB20D3103-SPE2DB24FL5Q7
Award Date
11/16/23
Potential Completion Date
11/17/23
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSPENSION 7.5ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,346.05 and an ultimate completion date of October 30, 2023. This is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 11, 2024, with a ceiling value of $1,383.00. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 12, 2024. This contract is not designated with...
This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $6,092.71, is a firm fixed price delivery order contract with an ultimate completion date of April 24, 2024. This contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award, valued at $1,326.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award covers the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, with an ultimate completion date of January 16, 2024. The contract is a Delivery Order under a Firm Fixed Price structure, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,347.22 and was awarded on May 17, 2022, with a completion date of May 18, 2022. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. There is no set-aside...
This federal contract award issued by the Defense Logistics Agency (DLA) is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to support military and government healthcare programs. The $9,776.24 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $4,545.32 for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 19, 2024. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $1,766.42 for CIPROFLOX-DEXAMETH OTIC SUSPENSION 7.5ML. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,435.14 firm fixed-price delivery order is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,274.40 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 25, 2023. The contract has an ultimate completion date of August 28, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...